Alloantigen processing and presentation

Same author

Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXT.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2018

Same author

De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2018

Same author

Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017

Same author

The Road to HLA Antibody Evaluation: Do Not Rely on MFI.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017

Same author

HLA compatibility assessment and management of highly sensitized patients under the new kidney allocation system (KAS): A 2016 status report from twelve HLA laboratories across the U.S.

Human immunology·2016

Same author

Hiding in Plain Sight-A New Look at HLA Epitopes: A Case Report.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016

Same journal

Alveolar macrophage activation and polarization signatures in stable lung transplant recipients and chronic lung allograft dysfunction.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Same journal

Distinct Metabolomic and Lipidomic Profiles Across Donation after Circulatory Death Recovery Strategies Reveal a Common Signature Associated with Primary Graft Dysfunction.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Same journal

Related Experiment Videos

Alloantigen processing and presentation

Related Concept Videos

Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXT.

De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies.

Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies.

The Road to HLA Antibody Evaluation: Do Not Rely on MFI.

HLA compatibility assessment and management of highly sensitized patients under the new kidney allocation system (KAS): A 2016 status report from twelve HLA laboratories across the U.S.

Hiding in Plain Sight-A New Look at HLA Epitopes: A Case Report.

Alveolar macrophage activation and polarization signatures in stable lung transplant recipients and chronic lung allograft dysfunction.

Distinct Metabolomic and Lipidomic Profiles Across Donation after Circulatory Death Recovery Strategies Reveal a Common Signature Associated with Primary Graft Dysfunction.

Antibody-mediated rejection after heart transplantation: diagnostic gaps, suboptimal outcomes, and emerging tools.

What sotatercept can teach us about the right ventricle in pulmonary arterial hypertension.

The Future of Heart Transplant Data Science Requires Common Data Models.

From Guideline to Practice: Operationalizing Telomere Length Testing in ILD and Lung Transplantation.

Related Experiment Videos

Alloantigen processing and presentation

Related Concept Videos

Related Articles

Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXT.

De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies.

Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies.

The Road to HLA Antibody Evaluation: Do Not Rely on MFI.

HLA compatibility assessment and management of highly sensitized patients under the new kidney allocation system (KAS): A 2016 status report from twelve HLA laboratories across the U.S.

Hiding in Plain Sight-A New Look at HLA Epitopes: A Case Report.

Alveolar macrophage activation and polarization signatures in stable lung transplant recipients and chronic lung allograft dysfunction.

Distinct Metabolomic and Lipidomic Profiles Across Donation after Circulatory Death Recovery Strategies Reveal a Common Signature Associated with Primary Graft Dysfunction.

Antibody-mediated rejection after heart transplantation: diagnostic gaps, suboptimal outcomes, and emerging tools.

What sotatercept can teach us about the right ventricle in pulmonary arterial hypertension.

The Future of Heart Transplant Data Science Requires Common Data Models.

From Guideline to Practice: Operationalizing Telomere Length Testing in ILD and Lung Transplantation.